Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma

Background: Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers in the world, the detection and prognosis of which are still unsatisfactory. Thus, it is essential to explore the factors that may identify ESCC and evaluate the prognosis of ESCC patients. Results: Both pro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zu-Xuan Chen, Guo-Sheng Li, Li-Hua Yang, He-Chuan Liu, Guang-Mei Qin, Lang Shen, Wei-Ying He, Ting-Qing Gan, Jian-Jun Li
Formato: article
Lenguaje:EN
Publicado: AIMS Press 2021
Materias:
Acceso en línea:https://doaj.org/article/0f20ac2ba4384a059d1523f8a078948c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0f20ac2ba4384a059d1523f8a078948c
record_format dspace
spelling oai:doaj.org-article:0f20ac2ba4384a059d1523f8a078948c2021-11-23T01:26:10ZUpregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma10.3934/mbe.20213451551-0018https://doaj.org/article/0f20ac2ba4384a059d1523f8a078948c2021-08-01T00:00:00Zhttps://www.aimspress.com/article/doi/10.3934/mbe.2021345?viewType=HTMLhttps://doaj.org/toc/1551-0018Background: Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers in the world, the detection and prognosis of which are still unsatisfactory. Thus, it is essential to explore the factors that may identify ESCC and evaluate the prognosis of ESCC patients. Results: Both protein and mRNA expression levels of BIRC5 are upregulated in ESCC group rather than non-ESCC group (standardized mean difference > 0). BIRC5 mRNA expression is related to the age, tumor location, lymph node stage and clinical stage of ESCC patients (p < 0.05). BIRC5 expression makes it feasible to distinguish ESCC from non-ESCC (area under the curve > 0.9), and its high expression is related to poor prognosis of ESCC patients (restrictive survival time difference = -0.036, p < 0.05). BIRC5 may play an important role in ESCC by influencing the cell cycle pathway, and CDK1, MAD2L and CDC20 may be the hub genes of this pathway. The transcription factors-MAZ and TFPD1 -are likely to regulate the transcription of BIRC5, which may be one of the factors for the high expression of BIRC5 in ESCC. Conclusions: The current study shows that upregulation of BIRC5 may have essential clinical value in ESCC, and contributes to the understanding of the pathogenesis of ESCC.Zu-Xuan ChenGuo-Sheng LiLi-Hua YangHe-Chuan Liu Guang-Mei QinLang ShenWei-Ying HeTing-Qing GanJian-Jun Li AIMS Pressarticleesophageal squamous cell carcinomabaculoviral inhibitor of apoptosis repeat containing 5microarrayrna sequencingprognosisBiotechnologyTP248.13-248.65MathematicsQA1-939ENMathematical Biosciences and Engineering, Vol 18, Iss 5, Pp 6941-6960 (2021)
institution DOAJ
collection DOAJ
language EN
topic esophageal squamous cell carcinoma
baculoviral inhibitor of apoptosis repeat containing 5
microarray
rna sequencing
prognosis
Biotechnology
TP248.13-248.65
Mathematics
QA1-939
spellingShingle esophageal squamous cell carcinoma
baculoviral inhibitor of apoptosis repeat containing 5
microarray
rna sequencing
prognosis
Biotechnology
TP248.13-248.65
Mathematics
QA1-939
Zu-Xuan Chen
Guo-Sheng Li
Li-Hua Yang
He-Chuan Liu
Guang-Mei Qin
Lang Shen
Wei-Ying He
Ting-Qing Gan
Jian-Jun Li
Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma
description Background: Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers in the world, the detection and prognosis of which are still unsatisfactory. Thus, it is essential to explore the factors that may identify ESCC and evaluate the prognosis of ESCC patients. Results: Both protein and mRNA expression levels of BIRC5 are upregulated in ESCC group rather than non-ESCC group (standardized mean difference > 0). BIRC5 mRNA expression is related to the age, tumor location, lymph node stage and clinical stage of ESCC patients (p < 0.05). BIRC5 expression makes it feasible to distinguish ESCC from non-ESCC (area under the curve > 0.9), and its high expression is related to poor prognosis of ESCC patients (restrictive survival time difference = -0.036, p < 0.05). BIRC5 may play an important role in ESCC by influencing the cell cycle pathway, and CDK1, MAD2L and CDC20 may be the hub genes of this pathway. The transcription factors-MAZ and TFPD1 -are likely to regulate the transcription of BIRC5, which may be one of the factors for the high expression of BIRC5 in ESCC. Conclusions: The current study shows that upregulation of BIRC5 may have essential clinical value in ESCC, and contributes to the understanding of the pathogenesis of ESCC.
format article
author Zu-Xuan Chen
Guo-Sheng Li
Li-Hua Yang
He-Chuan Liu
Guang-Mei Qin
Lang Shen
Wei-Ying He
Ting-Qing Gan
Jian-Jun Li
author_facet Zu-Xuan Chen
Guo-Sheng Li
Li-Hua Yang
He-Chuan Liu
Guang-Mei Qin
Lang Shen
Wei-Ying He
Ting-Qing Gan
Jian-Jun Li
author_sort Zu-Xuan Chen
title Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma
title_short Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma
title_full Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma
title_fullStr Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma
title_full_unstemmed Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma
title_sort upregulation of birc5 plays essential role in esophageal squamous cell carcinoma
publisher AIMS Press
publishDate 2021
url https://doaj.org/article/0f20ac2ba4384a059d1523f8a078948c
work_keys_str_mv AT zuxuanchen upregulationofbirc5playsessentialroleinesophagealsquamouscellcarcinoma
AT guoshengli upregulationofbirc5playsessentialroleinesophagealsquamouscellcarcinoma
AT lihuayang upregulationofbirc5playsessentialroleinesophagealsquamouscellcarcinoma
AT hechuanliu upregulationofbirc5playsessentialroleinesophagealsquamouscellcarcinoma
AT guangmeiqin upregulationofbirc5playsessentialroleinesophagealsquamouscellcarcinoma
AT langshen upregulationofbirc5playsessentialroleinesophagealsquamouscellcarcinoma
AT weiyinghe upregulationofbirc5playsessentialroleinesophagealsquamouscellcarcinoma
AT tingqinggan upregulationofbirc5playsessentialroleinesophagealsquamouscellcarcinoma
AT jianjunli upregulationofbirc5playsessentialroleinesophagealsquamouscellcarcinoma
_version_ 1718417361300619264